

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.99095508 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.99095508 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.47111247 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.62894540 |
| 5 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.09991338 |
| 6 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.75474919 |
| 7 | regulation of gamma-delta T cell activation (GO:0046643) | 3.70463082 |
| 8 | negative T cell selection (GO:0043383) | 3.48335926 |
| 9 | negative thymic T cell selection (GO:0045060) | 3.47417214 |
| 10 | positive thymic T cell selection (GO:0045059) | 3.35015759 |
| 11 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.28675966 |
| 12 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.27908675 |
| 13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.26335015 |
| 14 | valine metabolic process (GO:0006573) | 3.14185245 |
| 15 | mannose metabolic process (GO:0006013) | 3.12293722 |
| 16 | regulation of extracellular matrix disassembly (GO:0010715) | 3.09260240 |
| 17 | positive regulation of B cell differentiation (GO:0045579) | 3.04608208 |
| 18 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.02335233 |
| 19 | thymic T cell selection (GO:0045061) | 3.01617220 |
| 20 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.97050305 |
| 21 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.96884611 |
| 22 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.95535089 |
| 23 | response to peptidoglycan (GO:0032494) | 2.93536761 |
| 24 | regulation of response to interferon-gamma (GO:0060330) | 2.88655190 |
| 25 | positive regulation by symbiont of host defense response (GO:0052509) | 2.81618168 |
| 26 | modulation by symbiont of host defense response (GO:0052031) | 2.81618168 |
| 27 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.81618168 |
| 28 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.81618168 |
| 29 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.81618168 |
| 30 | modulation by symbiont of host immune response (GO:0052553) | 2.81618168 |
| 31 | interferon-gamma production (GO:0032609) | 2.81457539 |
| 32 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.78922142 |
| 33 | NIK/NF-kappaB signaling (GO:0038061) | 2.78796827 |
| 34 | response to interleukin-15 (GO:0070672) | 2.78476484 |
| 35 | urea metabolic process (GO:0019627) | 2.77758103 |
| 36 | urea cycle (GO:0000050) | 2.77758103 |
| 37 | barbed-end actin filament capping (GO:0051016) | 2.77496559 |
| 38 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.76621535 |
| 39 | response to type I interferon (GO:0034340) | 2.76194530 |
| 40 | kynurenine metabolic process (GO:0070189) | 2.74967399 |
| 41 | macrophage activation involved in immune response (GO:0002281) | 2.73954560 |
| 42 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.73923178 |
| 43 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.73735986 |
| 44 | regulation of B cell differentiation (GO:0045577) | 2.73617357 |
| 45 | immunoglobulin mediated immune response (GO:0016064) | 2.72223475 |
| 46 | cellular response to type I interferon (GO:0071357) | 2.70559803 |
| 47 | type I interferon signaling pathway (GO:0060337) | 2.70559803 |
| 48 | tryptophan catabolic process (GO:0006569) | 2.69228384 |
| 49 | indole-containing compound catabolic process (GO:0042436) | 2.69228384 |
| 50 | indolalkylamine catabolic process (GO:0046218) | 2.69228384 |
| 51 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.69027146 |
| 52 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.69027146 |
| 53 | ribosomal small subunit assembly (GO:0000028) | 2.66765037 |
| 54 | pinocytosis (GO:0006907) | 2.66720281 |
| 55 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.66136922 |
| 56 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.65330324 |
| 57 | negative regulation of cholesterol transport (GO:0032375) | 2.64385470 |
| 58 | negative regulation of sterol transport (GO:0032372) | 2.64385470 |
| 59 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.63744825 |
| 60 | L-phenylalanine metabolic process (GO:0006558) | 2.63744825 |
| 61 | positive regulation of humoral immune response (GO:0002922) | 2.63548161 |
| 62 | leukocyte aggregation (GO:0070486) | 2.62724592 |
| 63 | phospholipid efflux (GO:0033700) | 2.61914055 |
| 64 | T cell selection (GO:0045058) | 2.61761930 |
| 65 | aromatic amino acid family catabolic process (GO:0009074) | 2.61531197 |
| 66 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.59416510 |
| 67 | regulation of regulatory T cell differentiation (GO:0045589) | 2.58734072 |
| 68 | T cell migration (GO:0072678) | 2.57601394 |
| 69 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.56651868 |
| 70 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.56603377 |
| 71 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.55966924 |
| 72 | L-phenylalanine catabolic process (GO:0006559) | 2.55966924 |
| 73 | regulation of triglyceride catabolic process (GO:0010896) | 2.55633489 |
| 74 | regulation of necroptotic process (GO:0060544) | 2.54802388 |
| 75 | tryptophan metabolic process (GO:0006568) | 2.52966211 |
| 76 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.52078118 |
| 77 | positive T cell selection (GO:0043368) | 2.51418328 |
| 78 | B cell mediated immunity (GO:0019724) | 2.50774855 |
| 79 | hypotonic response (GO:0006971) | 2.50687896 |
| 80 | nitrogen cycle metabolic process (GO:0071941) | 2.50238996 |
| 81 | negative regulation of type 2 immune response (GO:0002829) | 2.49960922 |
| 82 | glycine metabolic process (GO:0006544) | 2.49167121 |
| 83 | detection of bacterium (GO:0016045) | 2.48867116 |
| 84 | hepatocyte apoptotic process (GO:0097284) | 2.48525169 |
| 85 | regulation of tolerance induction (GO:0002643) | 2.46977445 |
| 86 | positive regulation of tolerance induction (GO:0002645) | 2.44983715 |
| 87 | negative regulation of innate immune response (GO:0045824) | 2.44983201 |
| 88 | amyloid precursor protein catabolic process (GO:0042987) | 2.44498128 |
| 89 | alpha-linolenic acid metabolic process (GO:0036109) | 2.44161706 |
| 90 | positive regulation of interferon-alpha production (GO:0032727) | 2.43999816 |
| 91 | detection of other organism (GO:0098543) | 2.43376964 |
| 92 | neutrophil activation involved in immune response (GO:0002283) | 2.42545467 |
| 93 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.42493440 |
| 94 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.42146664 |
| 95 | 2-oxoglutarate metabolic process (GO:0006103) | 2.41953052 |
| 96 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.40664327 |
| 97 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.40301587 |
| 98 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.39556786 |
| 99 | negative regulation of phagocytosis (GO:0050765) | 2.39466801 |
| 100 | response to muramyl dipeptide (GO:0032495) | 2.39072868 |
| 101 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.38974997 |
| 102 | lysine metabolic process (GO:0006553) | 2.38916371 |
| 103 | lysine catabolic process (GO:0006554) | 2.38916371 |
| 104 | regulation of T cell tolerance induction (GO:0002664) | 2.36969562 |
| 105 | high-density lipoprotein particle remodeling (GO:0034375) | 2.36782586 |
| 106 | sulfur amino acid catabolic process (GO:0000098) | 2.36056801 |
| 107 | cysteine metabolic process (GO:0006534) | 2.35007879 |
| 108 | tolerance induction (GO:0002507) | 2.34963947 |
| 109 | membrane raft organization (GO:0031579) | 2.34029648 |
| 110 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.33854958 |
| 111 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.33306723 |
| 112 | response to interferon-beta (GO:0035456) | 2.31794863 |
| 113 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.31463963 |
| 114 | negative regulation of cell killing (GO:0031342) | 2.31463963 |
| 115 | Golgi transport vesicle coating (GO:0048200) | 2.31299432 |
| 116 | COPI coating of Golgi vesicle (GO:0048205) | 2.31299432 |
| 117 | glyoxylate metabolic process (GO:0046487) | 2.31205297 |
| 118 | embryonic process involved in female pregnancy (GO:0060136) | 2.31110064 |
| 119 | amino-acid betaine metabolic process (GO:0006577) | 2.31081758 |
| 120 | complement activation, alternative pathway (GO:0006957) | 2.31037448 |
| 121 | response to laminar fluid shear stress (GO:0034616) | 2.30873691 |
| 122 | positive regulation of response to tumor cell (GO:0002836) | 2.30091142 |
| 123 | positive regulation of immune response to tumor cell (GO:0002839) | 2.30091142 |
| 124 | regulation of immune response to tumor cell (GO:0002837) | 2.30091142 |
| 125 | regulation of response to tumor cell (GO:0002834) | 2.30091142 |
| 126 | regulation of cholesterol esterification (GO:0010872) | 2.29805961 |
| 127 | negative regulation of viral release from host cell (GO:1902187) | 2.29454386 |
| 128 | regulation of interferon-alpha production (GO:0032647) | 2.28737166 |
| 129 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.28512413 |
| 130 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.28372143 |
| 131 | response to host (GO:0075136) | 2.28372143 |
| 132 | response to host defenses (GO:0052200) | 2.28372143 |
| 133 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.27522694 |
| 134 | serine family amino acid biosynthetic process (GO:0009070) | 2.27279996 |
| 135 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.26776981 |
| 136 | T cell costimulation (GO:0031295) | 2.26565763 |
| 137 | detection of external biotic stimulus (GO:0098581) | 2.26042451 |
| 138 | regulation of necrotic cell death (GO:0010939) | 2.25675144 |
| 139 | positive regulation of isotype switching (GO:0045830) | 2.25016150 |
| 140 | desmosome organization (GO:0002934) | 2.24914574 |
| 141 | cellular response to exogenous dsRNA (GO:0071360) | 2.24386648 |
| 142 | negative regulation of fibrinolysis (GO:0051918) | 2.23711847 |
| 143 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.23232801 |
| 144 | cellular response to interleukin-15 (GO:0071350) | 2.23201932 |
| 145 | cellular response to zinc ion (GO:0071294) | 2.22612949 |
| 146 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.22463343 |
| 147 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.22250649 |
| 148 | B cell receptor signaling pathway (GO:0050853) | 2.22131232 |
| 149 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.22038459 |
| 150 | protein carboxylation (GO:0018214) | 2.22038459 |
| 151 | regulation of cholesterol homeostasis (GO:2000188) | 2.21561742 |
| 152 | cellular response to interferon-beta (GO:0035458) | 2.21182260 |
| 153 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.20183478 |
| 154 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.18129207 |
| 155 | regulation of antigen processing and presentation (GO:0002577) | 2.16833610 |
| 156 | mature B cell differentiation involved in immune response (GO:0002313) | 2.16746078 |
| 157 | positive regulation of histone deacetylation (GO:0031065) | 2.16543735 |
| 158 | response to host immune response (GO:0052572) | 2.16258750 |
| 159 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.16258750 |
| 160 | negative regulation of bone resorption (GO:0045779) | 2.16057412 |
| 161 | angiogenesis involved in wound healing (GO:0060055) | 2.15547710 |
| 162 | regulation of viral release from host cell (GO:1902186) | 2.13766165 |
| 163 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.13277990 |
| 164 | regulation of leukocyte degranulation (GO:0043300) | 2.11953262 |
| 165 | response to progesterone (GO:0032570) | 2.11186639 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.26275133 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.02992739 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.97484524 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.86530143 |
| 5 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.78290535 |
| 6 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.77896090 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.76177560 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.67202703 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.60772812 |
| 10 | MYC_22102868_ChIP-Seq_BL_Human | 2.57921121 |
| 11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.54152639 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.33029940 |
| 13 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.32093192 |
| 14 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.25811435 |
| 15 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.20865151 |
| 16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.14127206 |
| 17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.11824796 |
| 18 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.02192821 |
| 19 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.02132636 |
| 20 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 2.02091247 |
| 21 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.00989641 |
| 22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.00904732 |
| 23 | GATA1_22025678_ChIP-Seq_K562_Human | 1.98225815 |
| 24 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.97421941 |
| 25 | * MAF_26560356_Chip-Seq_TH1_Human | 1.96725629 |
| 26 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.95364875 |
| 27 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.89779785 |
| 28 | MYB_26560356_Chip-Seq_TH2_Human | 1.87758406 |
| 29 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.87446622 |
| 30 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.82478762 |
| 31 | * MYB_26560356_Chip-Seq_TH1_Human | 1.82045294 |
| 32 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.77893227 |
| 33 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77889693 |
| 34 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.73250142 |
| 35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.72846774 |
| 36 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.71656639 |
| 37 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.68465891 |
| 38 | UTX_26944678_Chip-Seq_JUKART_Human | 1.67301193 |
| 39 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.67024577 |
| 40 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.65277073 |
| 41 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.64856293 |
| 42 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.63149647 |
| 43 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.62193673 |
| 44 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.60542773 |
| 45 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.59473439 |
| 46 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.59355283 |
| 47 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.55586461 |
| 48 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.55389190 |
| 49 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.55187441 |
| 50 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.50939565 |
| 51 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.49491528 |
| 52 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.47468479 |
| 53 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.47087556 |
| 54 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.46938915 |
| 55 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.46874128 |
| 56 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.46857498 |
| 57 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46737490 |
| 58 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.45974641 |
| 59 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.45305517 |
| 60 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.44529404 |
| 61 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.40500372 |
| 62 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.39912462 |
| 63 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39630129 |
| 64 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.37354490 |
| 65 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.36505745 |
| 66 | * MAF_26560356_Chip-Seq_TH2_Human | 1.35946998 |
| 67 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.33139744 |
| 68 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.31944997 |
| 69 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.30089912 |
| 70 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.28588770 |
| 71 | P68_20966046_ChIP-Seq_HELA_Human | 1.28176098 |
| 72 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.27552968 |
| 73 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.27213792 |
| 74 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24599843 |
| 75 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.23532634 |
| 76 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.22775733 |
| 77 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.22596478 |
| 78 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.22126167 |
| 79 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20370348 |
| 80 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.20229696 |
| 81 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.19633928 |
| 82 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.19310902 |
| 83 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.18278678 |
| 84 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.18218775 |
| 85 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17581749 |
| 86 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.16679173 |
| 87 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.16596814 |
| 88 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.14805721 |
| 89 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.14690463 |
| 90 | ATF3_27146783_Chip-Seq_COLON_Human | 1.14467436 |
| 91 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.14304769 |
| 92 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.14187866 |
| 93 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.13389242 |
| 94 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.13123667 |
| 95 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.13003249 |
| 96 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.11878647 |
| 97 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.11289773 |
| 98 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.11166053 |
| 99 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10969436 |
| 100 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.10879260 |
| 101 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.10310650 |
| 102 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.09470118 |
| 103 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.08717885 |
| 104 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.05808221 |
| 105 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.03720180 |
| 106 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03291054 |
| 107 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.02758850 |
| 108 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.02239883 |
| 109 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.01571810 |
| 110 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.01183117 |
| 111 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.01132925 |
| 112 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98325505 |
| 113 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.96358688 |
| 114 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.96009665 |
| 115 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94972181 |
| 116 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94669185 |
| 117 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.94433263 |
| 118 | SPI1_23127762_ChIP-Seq_K562_Human | 0.94052225 |
| 119 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.93654538 |
| 120 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.93277751 |
| 121 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.92807622 |
| 122 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.91633279 |
| 123 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.91346536 |
| 124 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91081518 |
| 125 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.91036724 |
| 126 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.89740927 |
| 127 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88038867 |
| 128 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.87913218 |
| 129 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.85811202 |
| 130 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.85373305 |
| 131 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.85317230 |
| 132 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.83230861 |
| 133 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.83144402 |
| 134 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.82889413 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 3.35040263 |
| 2 | MP0001835_abnormal_antigen_presentation | 2.97605065 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 2.94725059 |
| 4 | MP0000685_abnormal_immune_system | 2.72486312 |
| 5 | MP0003763_abnormal_thymus_physiology | 2.61754283 |
| 6 | MP0005365_abnormal_bile_salt | 2.39508488 |
| 7 | MP0002166_altered_tumor_susceptibility | 2.39502087 |
| 8 | MP0005671_abnormal_response_to | 2.35224910 |
| 9 | MP0009840_abnormal_foam_cell | 2.34391297 |
| 10 | MP0005085_abnormal_gallbladder_physiolo | 2.31678516 |
| 11 | MP0001800_abnormal_humoral_immune | 2.27330996 |
| 12 | MP0003436_decreased_susceptibility_to | 2.20760242 |
| 13 | MP0001790_abnormal_immune_system | 2.07855575 |
| 14 | MP0005387_immune_system_phenotype | 2.07855575 |
| 15 | MP0009785_altered_susceptibility_to | 2.06668802 |
| 16 | MP0008875_abnormal_xenobiotic_pharmacok | 2.00069048 |
| 17 | MP0002396_abnormal_hematopoietic_system | 1.96224487 |
| 18 | MP0003300_gastrointestinal_ulcer | 1.94782904 |
| 19 | MP0005025_abnormal_response_to | 1.92601331 |
| 20 | MP0002452_abnormal_antigen_presenting | 1.89876388 |
| 21 | MP0003172_abnormal_lysosome_physiology | 1.88901818 |
| 22 | MP0002006_tumorigenesis | 1.87166463 |
| 23 | MP0002723_abnormal_immune_serum | 1.86876260 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 1.86763920 |
| 25 | MP0005000_abnormal_immune_tolerance | 1.86530622 |
| 26 | MP0001873_stomach_inflammation | 1.79840012 |
| 27 | MP0010352_gastrointestinal_tract_polyps | 1.79238529 |
| 28 | MP0002420_abnormal_adaptive_immunity | 1.78881665 |
| 29 | MP0001819_abnormal_immune_cell | 1.77202463 |
| 30 | MP0002398_abnormal_bone_marrow | 1.74453147 |
| 31 | MP0003806_abnormal_nucleotide_metabolis | 1.74077260 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.70772449 |
| 33 | MP0003724_increased_susceptibility_to | 1.70337101 |
| 34 | MP0005464_abnormal_platelet_physiology | 1.62457570 |
| 35 | MP0004947_skin_inflammation | 1.59867082 |
| 36 | MP0000716_abnormal_immune_system | 1.59690585 |
| 37 | MP0002419_abnormal_innate_immunity | 1.58182992 |
| 38 | MP0002405_respiratory_system_inflammati | 1.58142332 |
| 39 | MP0000689_abnormal_spleen_morphology | 1.57179492 |
| 40 | MP0003279_aneurysm | 1.55395066 |
| 41 | MP0010329_abnormal_lipoprotein_level | 1.54963911 |
| 42 | MP0009333_abnormal_splenocyte_physiolog | 1.54140476 |
| 43 | MP0001853_heart_inflammation | 1.54026097 |
| 44 | MP0002722_abnormal_immune_system | 1.53621556 |
| 45 | MP0002254_reproductive_system_inflammat | 1.53374425 |
| 46 | MP0003705_abnormal_hypodermis_morpholog | 1.52523486 |
| 47 | MP0000609_abnormal_liver_physiology | 1.51743394 |
| 48 | MP0003252_abnormal_bile_duct | 1.50804407 |
| 49 | MP0006082_CNS_inflammation | 1.49905666 |
| 50 | MP0002148_abnormal_hypersensitivity_rea | 1.49131432 |
| 51 | MP0008438_abnormal_cutaneous_collagen | 1.46609388 |
| 52 | MP0004185_abnormal_adipocyte_glucose | 1.45682317 |
| 53 | MP0001666_abnormal_nutrient_absorption | 1.42746307 |
| 54 | MP0001845_abnormal_inflammatory_respons | 1.42566786 |
| 55 | MP0002138_abnormal_hepatobiliary_system | 1.39978756 |
| 56 | MP0002429_abnormal_blood_cell | 1.38915364 |
| 57 | MP0008469_abnormal_protein_level | 1.38616900 |
| 58 | MP0002877_abnormal_melanocyte_morpholog | 1.34463166 |
| 59 | MP0003045_fibrosis | 1.34346759 |
| 60 | MP0001958_emphysema | 1.33905419 |
| 61 | MP0002998_abnormal_bone_remodeling | 1.30030559 |
| 62 | MP0003866_abnormal_defecation | 1.25782969 |
| 63 | MP0002796_impaired_skin_barrier | 1.25247384 |
| 64 | MP0000703_abnormal_thymus_morphology | 1.23148237 |
| 65 | MP0003091_abnormal_cell_migration | 1.22176211 |
| 66 | MP0002933_joint_inflammation | 1.21525872 |
| 67 | MP0001545_abnormal_hematopoietic_system | 1.19784520 |
| 68 | MP0005397_hematopoietic_system_phenotyp | 1.19784520 |
| 69 | MP0003303_peritoneal_inflammation | 1.18306646 |
| 70 | MP0005319_abnormal_enzyme/_coenzyme | 1.17010056 |
| 71 | MP0003183_abnormal_peptide_metabolism | 1.15023133 |
| 72 | MP0005332_abnormal_amino_acid | 1.11890794 |
| 73 | MP0003075_altered_response_to | 1.11444193 |
| 74 | MP0009643_abnormal_urine_homeostasis | 1.11292644 |
| 75 | MP0008260_abnormal_autophagy | 1.09589301 |
| 76 | MP0005083_abnormal_biliary_tract | 1.07664059 |
| 77 | MP0000490_abnormal_crypts_of | 1.06248262 |
| 78 | MP0003693_abnormal_embryo_hatching | 1.05516070 |
| 79 | MP0004808_abnormal_hematopoietic_stem | 1.03535701 |
| 80 | MP0000465_gastrointestinal_hemorrhage | 1.03527794 |
| 81 | MP0002132_abnormal_respiratory_system | 1.02829781 |
| 82 | MP0001533_abnormal_skeleton_physiology | 1.01045996 |
| 83 | MP0003186_abnormal_redox_activity | 1.00911569 |
| 84 | MP0005666_abnormal_adipose_tissue | 1.00847265 |
| 85 | MP0005375_adipose_tissue_phenotype | 0.99893079 |
| 86 | MP0000598_abnormal_liver_morphology | 0.99558287 |
| 87 | MP0002019_abnormal_tumor_incidence | 0.99035099 |
| 88 | MP0000858_altered_metastatic_potential | 0.98517637 |
| 89 | MP0005166_decreased_susceptibility_to | 0.98488629 |
| 90 | MP0005023_abnormal_wound_healing | 0.98470925 |
| 91 | MP0001849_ear_inflammation | 0.98281089 |
| 92 | MP0000678_abnormal_parathyroid_gland | 0.97901085 |
| 93 | MP0009763_increased_sensitivity_to | 0.97871505 |
| 94 | MP0010234_abnormal_vibrissa_follicle | 0.97798824 |
| 95 | MP0005310_abnormal_salivary_gland | 0.97409089 |
| 96 | MP0002060_abnormal_skin_morphology | 0.96492768 |
| 97 | MP0000681_abnormal_thyroid_gland | 0.95593648 |
| 98 | MP0005670_abnormal_white_adipose | 0.94684290 |
| 99 | MP0009764_decreased_sensitivity_to | 0.94396312 |
| 100 | MP0001348_abnormal_lacrimal_gland | 0.93908675 |
| 101 | MP0000013_abnormal_adipose_tissue | 0.92565099 |
| 102 | MP0001764_abnormal_homeostasis | 0.92299544 |
| 103 | MP0003656_abnormal_erythrocyte_physiolo | 0.92293349 |
| 104 | MP0008057_abnormal_DNA_replication | 0.92010287 |
| 105 | MP0002136_abnormal_kidney_physiology | 0.91272014 |
| 106 | MP0005076_abnormal_cell_differentiation | 0.90241155 |
| 107 | MP0005058_abnormal_lysosome_morphology | 0.89514045 |
| 108 | MP0004019_abnormal_vitamin_homeostasis | 0.89396674 |
| 109 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.88672652 |
| 110 | MP0003828_pulmonary_edema | 0.88515168 |
| 111 | MP0005075_abnormal_melanosome_morpholog | 0.87818957 |
| 112 | MP0000003_abnormal_adipose_tissue | 0.87779525 |
| 113 | MP0004858_abnormal_nervous_system | 0.87034232 |
| 114 | MP0004510_myositis | 0.86446914 |
| 115 | MP0002118_abnormal_lipid_homeostasis | 0.85287572 |
| 116 | MP0005390_skeleton_phenotype | 0.84706156 |
| 117 | MP0005451_abnormal_body_composition | 0.83972900 |
| 118 | MP0003566_abnormal_cell_adhesion | 0.83907566 |
| 119 | MP0000249_abnormal_blood_vessel | 0.83905096 |
| 120 | MP0003795_abnormal_bone_structure | 0.83167683 |
| 121 | MP0003448_altered_tumor_morphology | 0.82226350 |
| 122 | MP0003453_abnormal_keratinocyte_physiol | 0.81291053 |
| 123 | MP0005164_abnormal_response_to | 0.80208655 |
| 124 | MP0006054_spinal_hemorrhage | 0.79836288 |
| 125 | MP0005165_increased_susceptibility_to | 0.79629555 |
| 126 | MP0004264_abnormal_extraembryonic_tissu | 0.79233971 |
| 127 | MP0010307_abnormal_tumor_latency | 0.76240124 |
| 128 | MP0001216_abnormal_epidermal_layer | 0.71191580 |
| 129 | MP0001851_eye_inflammation | 0.67930440 |
| 130 | MP0009278_abnormal_bone_marrow | 0.67565209 |
| 131 | MP0000477_abnormal_intestine_morphology | 0.67337148 |
| 132 | MP0010094_abnormal_chromosome_stability | 0.66868416 |
| 133 | MP0004957_abnormal_blastocyst_morpholog | 0.66400093 |
| 134 | MP0003077_abnormal_cell_cycle | 0.65785314 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 3.72530278 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.72530278 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.72530278 |
| 4 | Chronic otitis media (HP:0000389) | 3.39288335 |
| 5 | IgM deficiency (HP:0002850) | 3.30907206 |
| 6 | Recurrent viral infections (HP:0004429) | 3.24925196 |
| 7 | Recurrent fungal infections (HP:0002841) | 3.24587583 |
| 8 | Eczematoid dermatitis (HP:0000976) | 3.19923415 |
| 9 | Pustule (HP:0200039) | 3.19209777 |
| 10 | Recurrent bronchitis (HP:0002837) | 3.09108771 |
| 11 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.07543066 |
| 12 | Abnormality of T cell number (HP:0011839) | 3.06803425 |
| 13 | T lymphocytopenia (HP:0005403) | 3.06655958 |
| 14 | Autoimmune thrombocytopenia (HP:0001973) | 3.05412153 |
| 15 | Thrombocytosis (HP:0001894) | 3.01931035 |
| 16 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.01077033 |
| 17 | Deep venous thrombosis (HP:0002625) | 2.97047692 |
| 18 | Abnormality of T cells (HP:0002843) | 2.95754060 |
| 19 | Hypobetalipoproteinemia (HP:0003563) | 2.94217349 |
| 20 | Abnormality of macrophages (HP:0004311) | 2.94084140 |
| 21 | Xanthomatosis (HP:0000991) | 2.94005286 |
| 22 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.93646939 |
| 23 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.93646939 |
| 24 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.93646939 |
| 25 | Nasal polyposis (HP:0100582) | 2.90534790 |
| 26 | Dysostosis multiplex (HP:0000943) | 2.88204097 |
| 27 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.87293372 |
| 28 | Recurrent cutaneous fungal infections (HP:0011370) | 2.87293372 |
| 29 | Intrahepatic cholestasis (HP:0001406) | 2.86503703 |
| 30 | Combined immunodeficiency (HP:0005387) | 2.86019237 |
| 31 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.83205595 |
| 32 | Abnormality of T cell physiology (HP:0011840) | 2.74384339 |
| 33 | Severe combined immunodeficiency (HP:0004430) | 2.71659107 |
| 34 | Vertebral compression fractures (HP:0002953) | 2.69290645 |
| 35 | Recurrent bacterial skin infections (HP:0005406) | 2.68971559 |
| 36 | Myocardial infarction (HP:0001658) | 2.68889367 |
| 37 | Panhypogammaglobulinemia (HP:0003139) | 2.68740044 |
| 38 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.67861048 |
| 39 | Myositis (HP:0100614) | 2.67281349 |
| 40 | Gingival bleeding (HP:0000225) | 2.67240582 |
| 41 | Mucopolysacchariduria (HP:0008155) | 2.66553144 |
| 42 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.66553144 |
| 43 | Abnormality of the nasal mucosa (HP:0000433) | 2.64306993 |
| 44 | Recurrent abscess formation (HP:0002722) | 2.61705641 |
| 45 | Recurrent skin infections (HP:0001581) | 2.56306667 |
| 46 | Orchitis (HP:0100796) | 2.50163323 |
| 47 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.48611335 |
| 48 | Prolonged partial thromboplastin time (HP:0003645) | 2.48087730 |
| 49 | Spontaneous hematomas (HP:0007420) | 2.47332130 |
| 50 | Cervical subluxation (HP:0003308) | 2.45802991 |
| 51 | Inflammation of the large intestine (HP:0002037) | 2.44438072 |
| 52 | Increased IgM level (HP:0003496) | 2.42882138 |
| 53 | Gastrointestinal inflammation (HP:0004386) | 2.40101092 |
| 54 | Hyperammonemia (HP:0001987) | 2.38792125 |
| 55 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.38580932 |
| 56 | Distal lower limb muscle weakness (HP:0009053) | 2.34009902 |
| 57 | Protrusio acetabuli (HP:0003179) | 2.33953439 |
| 58 | Chronic diarrhea (HP:0002028) | 2.32602651 |
| 59 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.31958306 |
| 60 | IgG deficiency (HP:0004315) | 2.31923798 |
| 61 | Agammaglobulinemia (HP:0004432) | 2.29933447 |
| 62 | Fatigue (HP:0012378) | 2.27853466 |
| 63 | Gingivitis (HP:0000230) | 2.26866277 |
| 64 | Abnormality of the common coagulation pathway (HP:0010990) | 2.26260109 |
| 65 | Joint hemorrhage (HP:0005261) | 2.26174296 |
| 66 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.26105140 |
| 67 | Colitis (HP:0002583) | 2.24190700 |
| 68 | Epistaxis (HP:0000421) | 2.23057272 |
| 69 | Complement deficiency (HP:0004431) | 2.22738087 |
| 70 | Hyperlipoproteinemia (HP:0010980) | 2.21537877 |
| 71 | Interstitial pulmonary disease (HP:0006530) | 2.20954175 |
| 72 | Hypolipoproteinemia (HP:0010981) | 2.20690700 |
| 73 | Lymphopenia (HP:0001888) | 2.16993545 |
| 74 | Periodontitis (HP:0000704) | 2.16654618 |
| 75 | Emphysema (HP:0002097) | 2.16619526 |
| 76 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.16568293 |
| 77 | Abnormal platelet volume (HP:0011876) | 2.16368431 |
| 78 | Malnutrition (HP:0004395) | 2.16208538 |
| 79 | Pulmonary infiltrates (HP:0002113) | 2.13646613 |
| 80 | Glucose intolerance (HP:0000833) | 2.13549229 |
| 81 | Obstructive sleep apnea (HP:0002870) | 2.11255812 |
| 82 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.10983238 |
| 83 | Esophageal varix (HP:0002040) | 2.09881748 |
| 84 | Broad face (HP:0000283) | 2.09567297 |
| 85 | Premature rupture of membranes (HP:0001788) | 2.09077765 |
| 86 | Autoimmune hemolytic anemia (HP:0001890) | 2.09017172 |
| 87 | Spondylolisthesis (HP:0003302) | 2.08673343 |
| 88 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.07671471 |
| 89 | Petechiae (HP:0000967) | 2.07652363 |
| 90 | Progressive neurologic deterioration (HP:0002344) | 2.07594353 |
| 91 | Increased cerebral lipofuscin (HP:0011813) | 2.06954525 |
| 92 | IgA deficiency (HP:0002720) | 2.06822422 |
| 93 | Joint swelling (HP:0001386) | 2.06241069 |
| 94 | Vasculitis (HP:0002633) | 2.05884933 |
| 95 | Hypoplasia of the thymus (HP:0000778) | 2.05204076 |
| 96 | Thyroiditis (HP:0100646) | 2.04644147 |
| 97 | Meningitis (HP:0001287) | 2.04182693 |
| 98 | Granulocytopenia (HP:0001913) | 2.03509871 |
| 99 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.03011363 |
| 100 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.02582154 |
| 101 | Vacuolated lymphocytes (HP:0001922) | 2.02479291 |
| 102 | Loss of speech (HP:0002371) | 2.00904615 |
| 103 | Verrucae (HP:0200043) | 1.99934651 |
| 104 | Papilloma (HP:0012740) | 1.99934651 |
| 105 | Cellulitis (HP:0100658) | 1.99834244 |
| 106 | Eosinophilia (HP:0001880) | 1.99679935 |
| 107 | Fat malabsorption (HP:0002630) | 1.99327340 |
| 108 | Abnormality of eosinophils (HP:0001879) | 1.98210075 |
| 109 | Arterial thrombosis (HP:0004420) | 1.98103057 |
| 110 | Obstructive lung disease (HP:0006536) | 1.97874472 |
| 111 | Chronic obstructive pulmonary disease (HP:0006510) | 1.97874472 |
| 112 | Flat acetabular roof (HP:0003180) | 1.97488619 |
| 113 | Optic neuritis (HP:0100653) | 1.96895878 |
| 114 | Retrobulbar optic neuritis (HP:0100654) | 1.96895878 |
| 115 | Encephalitis (HP:0002383) | 1.95840857 |
| 116 | Purpura (HP:0000979) | 1.95256859 |
| 117 | Mediastinal lymphadenopathy (HP:0100721) | 1.94513194 |
| 118 | Increased IgE level (HP:0003212) | 1.94383989 |
| 119 | Growth hormone excess (HP:0000845) | 1.94134720 |
| 120 | Aortic aneurysm (HP:0004942) | 1.92592873 |
| 121 | Leukocytosis (HP:0001974) | 1.92435790 |
| 122 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.92255989 |
| 123 | Stridor (HP:0010307) | 1.92058243 |
| 124 | B lymphocytopenia (HP:0010976) | 1.91943396 |
| 125 | Abnormality of B cell number (HP:0010975) | 1.91943396 |
| 126 | Hypergammaglobulinemia (HP:0010702) | 1.91837210 |
| 127 | Osteolytic defects of the hand bones (HP:0009699) | 1.90928304 |
| 128 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.90928304 |
| 129 | Mitral stenosis (HP:0001718) | 1.90674164 |
| 130 | Epidermoid cyst (HP:0200040) | 1.89829808 |
| 131 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.89427570 |
| 132 | Increased mean platelet volume (HP:0011877) | 1.88277859 |
| 133 | Polycythemia (HP:0001901) | 1.88112053 |
| 134 | Polygenic inheritance (HP:0010982) | 1.88060495 |
| 135 | Hemorrhage of the eye (HP:0011885) | 1.87806741 |
| 136 | Abnormality of the intrinsic pathway (HP:0010989) | 1.87624767 |
| 137 | Nonimmune hydrops fetalis (HP:0001790) | 1.87525325 |
| 138 | Cheilitis (HP:0100825) | 1.87448334 |
| 139 | Increased connective tissue (HP:0009025) | 1.87221668 |
| 140 | Abnormality of the fingertips (HP:0001211) | 1.86302940 |
| 141 | Skin rash (HP:0000988) | 1.86291317 |
| 142 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.85927847 |
| 143 | Short nail (HP:0001799) | 1.85509999 |
| 144 | Abnormality of complement system (HP:0005339) | 1.85283610 |
| 145 | Hyperglycinuria (HP:0003108) | 1.85246282 |
| 146 | Impaired platelet aggregation (HP:0003540) | 1.84979308 |
| 147 | Abnormal platelet function (HP:0011869) | 1.84979308 |
| 148 | Asymmetric septal hypertrophy (HP:0001670) | 1.84892269 |
| 149 | Systemic lupus erythematosus (HP:0002725) | 1.84490969 |
| 150 | Gastrointestinal stroma tumor (HP:0100723) | 1.84220957 |
| 151 | Thrombophlebitis (HP:0004418) | 1.84123234 |
| 152 | Hypertriglyceridemia (HP:0002155) | 1.83042906 |
| 153 | Dilatation of the ascending aorta (HP:0005111) | 1.76726743 |
| 154 | Increased serum ferritin (HP:0003281) | 1.75620553 |
| 155 | Generalized amyotrophy (HP:0003700) | 1.74942529 |
| 156 | Urticaria (HP:0001025) | 1.74406070 |
| 157 | Joint stiffness (HP:0001387) | 1.74228668 |
| 158 | Advanced eruption of teeth (HP:0006288) | 1.74099658 |
| 159 | Hemoptysis (HP:0002105) | 1.74041665 |
| 160 | Prolonged bleeding time (HP:0003010) | 1.73337941 |
| 161 | Gastrointestinal infarctions (HP:0005244) | 1.71276361 |
| 162 | J-shaped sella turcica (HP:0002680) | 1.70641601 |
| 163 | Cerebral aneurysm (HP:0004944) | 1.70461310 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.63179374 |
| 2 | FGFR4 | 3.30653299 |
| 3 | JAK3 | 2.96253145 |
| 4 | SMG1 | 2.91607179 |
| 5 | TYK2 | 2.87014138 |
| 6 | EEF2K | 2.33864962 |
| 7 | ERN1 | 2.33607465 |
| 8 | TRIB3 | 2.21364246 |
| 9 | TXK | 2.21092788 |
| 10 | ZAP70 | 2.20558819 |
| 11 | TBK1 | 2.09857674 |
| 12 | IKBKE | 2.08166533 |
| 13 | GRK6 | 2.01776312 |
| 14 | KIT | 2.01048059 |
| 15 | STK10 | 1.99545699 |
| 16 | MAP3K14 | 1.97000527 |
| 17 | MAP3K10 | 1.95843666 |
| 18 | PRPF4B | 1.95269603 |
| 19 | PKN2 | 1.94943537 |
| 20 | BLK | 1.92192898 |
| 21 | KDR | 1.81518720 |
| 22 | FLT3 | 1.78718262 |
| 23 | FGFR3 | 1.68726107 |
| 24 | JAK1 | 1.67639438 |
| 25 | BTK | 1.65805979 |
| 26 | NME2 | 1.65368741 |
| 27 | TESK1 | 1.64285273 |
| 28 | BCKDK | 1.58731873 |
| 29 | LRRK2 | 1.56332506 |
| 30 | NLK | 1.53750557 |
| 31 | ITK | 1.52942813 |
| 32 | CSF1R | 1.51558227 |
| 33 | IRAK3 | 1.49784707 |
| 34 | TNK2 | 1.48117714 |
| 35 | RIPK4 | 1.47816578 |
| 36 | MAP2K3 | 1.45621564 |
| 37 | SIK1 | 1.40158651 |
| 38 | TGFBR2 | 1.32375914 |
| 39 | MST4 | 1.31319990 |
| 40 | TEC | 1.30343271 |
| 41 | PRKD2 | 1.29507631 |
| 42 | CDK12 | 1.28466839 |
| 43 | SYK | 1.26183792 |
| 44 | HIPK2 | 1.22953964 |
| 45 | MAP3K3 | 1.20055863 |
| 46 | IKBKB | 1.19905129 |
| 47 | EPHB1 | 1.19425491 |
| 48 | MAPK11 | 1.18939974 |
| 49 | LCK | 1.15329426 |
| 50 | CDC42BPA | 1.14087167 |
| 51 | CDK4 | 1.13461717 |
| 52 | ICK | 1.09300437 |
| 53 | CSK | 1.05567842 |
| 54 | RPS6KA4 | 1.05161476 |
| 55 | STK38 | 1.04650427 |
| 56 | PIM1 | 1.00207020 |
| 57 | NEK9 | 0.98995664 |
| 58 | TAOK3 | 0.96063252 |
| 59 | FES | 0.95956111 |
| 60 | IRAK4 | 0.95556193 |
| 61 | RPS6KB2 | 0.95406051 |
| 62 | PDPK1 | 0.94957652 |
| 63 | TGFBR1 | 0.94508557 |
| 64 | MAP3K1 | 0.93778861 |
| 65 | JAK2 | 0.92845500 |
| 66 | TTN | 0.91983568 |
| 67 | PTK6 | 0.88517436 |
| 68 | HCK | 0.88510464 |
| 69 | MYLK | 0.87754144 |
| 70 | SCYL2 | 0.84177534 |
| 71 | PIM2 | 0.80169987 |
| 72 | TAOK2 | 0.79499326 |
| 73 | PRKCI | 0.79054302 |
| 74 | CHUK | 0.78830704 |
| 75 | MARK2 | 0.77770079 |
| 76 | MST1R | 0.76361104 |
| 77 | MAP3K11 | 0.75608587 |
| 78 | LYN | 0.73178224 |
| 79 | EPHA3 | 0.72677572 |
| 80 | RPS6KA2 | 0.69637929 |
| 81 | TESK2 | 0.69619576 |
| 82 | PTK2 | 0.69189482 |
| 83 | CDK6 | 0.66560766 |
| 84 | MAP3K7 | 0.65815418 |
| 85 | LMTK2 | 0.65338905 |
| 86 | MAPK15 | 0.64138021 |
| 87 | ACVR1B | 0.63564567 |
| 88 | RIPK1 | 0.61448671 |
| 89 | STK4 | 0.61029607 |
| 90 | MAP3K8 | 0.59205228 |
| 91 | RPS6KC1 | 0.58613762 |
| 92 | RPS6KL1 | 0.58613762 |
| 93 | EPHA2 | 0.58005308 |
| 94 | FRK | 0.56958300 |
| 95 | MAP3K2 | 0.56910525 |
| 96 | FGR | 0.56757122 |
| 97 | MARK3 | 0.56270440 |
| 98 | MTOR | 0.56117471 |
| 99 | MAPKAPK3 | 0.55629682 |
| 100 | FER | 0.54398057 |
| 101 | NEK2 | 0.54028305 |
| 102 | SIK3 | 0.53641205 |
| 103 | ABL2 | 0.49354091 |
| 104 | MAP3K13 | 0.48876862 |
| 105 | PAK4 | 0.47183653 |
| 106 | MAP2K6 | 0.45793671 |
| 107 | TRPM7 | 0.45778549 |
| 108 | WEE1 | 0.44690671 |
| 109 | RPS6KA6 | 0.43332712 |
| 110 | TSSK6 | 0.41336852 |
| 111 | MAPK4 | 0.40834444 |
| 112 | CLK1 | 0.37657250 |
| 113 | PRKCQ | 0.37502259 |
| 114 | PRKG2 | 0.37480493 |
| 115 | TAOK1 | 0.35932306 |
| 116 | MAP2K2 | 0.35806830 |
| 117 | EIF2AK1 | 0.35207010 |
| 118 | AURKB | 0.32788426 |
| 119 | PDK1 | 0.32166041 |
| 120 | PRKAA2 | 0.32146625 |
| 121 | ABL1 | 0.31978763 |
| 122 | MAPKAPK2 | 0.31738362 |
| 123 | MAPK12 | 0.30013986 |
| 124 | SIK2 | 0.29949783 |
| 125 | BRSK2 | 0.29580497 |
| 126 | PRKCD | 0.29338173 |
| 127 | MELK | 0.28973117 |
| 128 | NUAK1 | 0.28503098 |
| 129 | CDK9 | 0.27548417 |
| 130 | PRKCH | 0.27246868 |
| 131 | PASK | 0.27180820 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.93569931 |
| 2 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.58574309 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.50051161 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.49270461 |
| 5 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.34218153 |
| 6 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.32214169 |
| 7 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.31111796 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.93237486 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.91049461 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.81360535 |
| 11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.80721442 |
| 12 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.74723250 |
| 13 | Lysosome_Homo sapiens_hsa04142 | 1.73095240 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.70362902 |
| 15 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.67513694 |
| 16 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.62014439 |
| 17 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.61833377 |
| 18 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.61072520 |
| 19 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.56580828 |
| 20 | DNA replication_Homo sapiens_hsa03030 | 1.54798710 |
| 21 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.53057560 |
| 22 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.52597369 |
| 23 | Measles_Homo sapiens_hsa05162 | 1.51890418 |
| 24 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.51142776 |
| 25 | Asthma_Homo sapiens_hsa05310 | 1.44602511 |
| 26 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.44524944 |
| 27 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.40646473 |
| 28 | Leishmaniasis_Homo sapiens_hsa05140 | 1.37787890 |
| 29 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.35693612 |
| 30 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.34072647 |
| 31 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.31985733 |
| 32 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.30035717 |
| 33 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.23541631 |
| 34 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.20317197 |
| 35 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.19082188 |
| 36 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.18454966 |
| 37 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.16705256 |
| 38 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.16689672 |
| 39 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.16385806 |
| 40 | Peroxisome_Homo sapiens_hsa04146 | 1.14681802 |
| 41 | Sulfur relay system_Homo sapiens_hsa04122 | 1.14174606 |
| 42 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.12343279 |
| 43 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.12169909 |
| 44 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.11487107 |
| 45 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.09005978 |
| 46 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.08108123 |
| 47 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.07189884 |
| 48 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.07140743 |
| 49 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.07046075 |
| 50 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.05099732 |
| 51 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.04822677 |
| 52 | Ribosome_Homo sapiens_hsa03010 | 1.04799652 |
| 53 | Mismatch repair_Homo sapiens_hsa03430 | 1.03782253 |
| 54 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.03142780 |
| 55 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.03114501 |
| 56 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.00459622 |
| 57 | Legionellosis_Homo sapiens_hsa05134 | 1.00375254 |
| 58 | Carbon metabolism_Homo sapiens_hsa01200 | 0.98413386 |
| 59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.98172812 |
| 60 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.98019804 |
| 61 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.96525524 |
| 62 | Histidine metabolism_Homo sapiens_hsa00340 | 0.94937741 |
| 63 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.93962268 |
| 64 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.93539521 |
| 65 | Base excision repair_Homo sapiens_hsa03410 | 0.92293957 |
| 66 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.91341533 |
| 67 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.91287404 |
| 68 | ABC transporters_Homo sapiens_hsa02010 | 0.90939547 |
| 69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.90400254 |
| 70 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.89463611 |
| 71 | Allograft rejection_Homo sapiens_hsa05330 | 0.88621209 |
| 72 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.85934215 |
| 73 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.84848952 |
| 74 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.84311219 |
| 75 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.83584120 |
| 76 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.81202517 |
| 77 | Influenza A_Homo sapiens_hsa05164 | 0.79901001 |
| 78 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.79299629 |
| 79 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.79237533 |
| 80 | Lysine degradation_Homo sapiens_hsa00310 | 0.79053764 |
| 81 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.77883878 |
| 82 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.77667825 |
| 83 | Retinol metabolism_Homo sapiens_hsa00830 | 0.76607985 |
| 84 | Phagosome_Homo sapiens_hsa04145 | 0.76164853 |
| 85 | Endocytosis_Homo sapiens_hsa04144 | 0.74356892 |
| 86 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.74028386 |
| 87 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.73044815 |
| 88 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.72770617 |
| 89 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.71366201 |
| 90 | Bladder cancer_Homo sapiens_hsa05219 | 0.71345453 |
| 91 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.71141709 |
| 92 | Viral myocarditis_Homo sapiens_hsa05416 | 0.70832952 |
| 93 | Platelet activation_Homo sapiens_hsa04611 | 0.70568619 |
| 94 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.70564729 |
| 95 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.70333597 |
| 96 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.69697703 |
| 97 | Apoptosis_Homo sapiens_hsa04210 | 0.69110183 |
| 98 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.68252016 |
| 99 | HTLV-I infection_Homo sapiens_hsa05166 | 0.67939405 |
| 100 | Galactose metabolism_Homo sapiens_hsa00052 | 0.67670259 |
| 101 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.65839678 |
| 102 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.64621488 |
| 103 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.62184735 |
| 104 | Malaria_Homo sapiens_hsa05144 | 0.62149490 |
| 105 | Focal adhesion_Homo sapiens_hsa04510 | 0.62002966 |
| 106 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.61345710 |
| 107 | Hepatitis B_Homo sapiens_hsa05161 | 0.61224280 |
| 108 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.61001206 |
| 109 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.60971202 |
| 110 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.59282889 |
| 111 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.58997550 |
| 112 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.58799477 |
| 113 | Amoebiasis_Homo sapiens_hsa05146 | 0.58014113 |
| 114 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.57675571 |
| 115 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.56674351 |
| 116 | Pertussis_Homo sapiens_hsa05133 | 0.56116643 |
| 117 | Salmonella infection_Homo sapiens_hsa05132 | 0.55791031 |
| 118 | Other glycan degradation_Homo sapiens_hsa00511 | 0.55346594 |
| 119 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.55334495 |
| 120 | Hepatitis C_Homo sapiens_hsa05160 | 0.55288104 |
| 121 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.55258650 |
| 122 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.53952561 |
| 123 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.53169435 |
| 124 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.53082141 |
| 125 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.53056481 |
| 126 | Proteasome_Homo sapiens_hsa03050 | 0.50940731 |
| 127 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.50643129 |
| 128 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.50050718 |
| 129 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.49992843 |
| 130 | Shigellosis_Homo sapiens_hsa05131 | 0.49873394 |
| 131 | Bile secretion_Homo sapiens_hsa04976 | 0.49165869 |
| 132 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.48694617 |
| 133 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.47988830 |
| 134 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.47452107 |
| 135 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.46984012 |
| 136 | Tuberculosis_Homo sapiens_hsa05152 | 0.46774351 |
| 137 | Insulin resistance_Homo sapiens_hsa04931 | 0.45956306 |
| 138 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.45498900 |
| 139 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.44865639 |
| 140 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.44538761 |
| 141 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.43933501 |
| 142 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.43687776 |
| 143 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.43516194 |
| 144 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43289186 |
| 145 | Prostate cancer_Homo sapiens_hsa05215 | 0.42464531 |
| 146 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.42425485 |

